Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pieper

Showing results (121-130 of 278) with videos related to

Pageof 28
Sort By:
Journal of the American Association for Laboratory Animal Science : JAALAS|July 11, 2012
Normal hematologic and serum biochemical values of cotton-top tamarins (Saguinus oedipus)Evan T Shukan, Carla Y Boe, Aimee V Hasenfus, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Propranolol pharmacokinetics and pharmacodynamics after single doses and at steady-stateR L Lalonde, J A Pieper, R J Straka, et al.
Clinical Pharmacology and Therapeutics|July 1, 1988
Effect of calcium channel blockers on theophylline dispositionS M Sirmans, J A Pieper, R L Lalonde, et al.
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1987
Propranolol pharmacodynamic modeling using unbound and total concentrations in healthy volunteersR L Lalonde, R J Straka, J A Pieper, et al.
The Journal of Prevention of Alzheimer'S Disease|October 27, 2025
The role for artificial intelligence in identifying combination therapies for Alzheimer's diseaseFeixiong Cheng, Zhendong Sha, Yadi Zhou, et al.
Journal of Pharmaceutical Sciences|July 1, 1987
Nonlinear pharmacokinetics of unbound propranolol after oral administrationR J Straka, R L Lalonde, J A Pieper, et al.
Journal of Clinical Pharmacology|April 10, 1999
The effects of fluvastatin, a CYP2C9 inhibitor, on losartan pharmacokinetics in healthy volunteersA M Meadowcroft, K M Williamson, J H Patterson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 9, 2025
Comprehensive characterization of the RNA editing landscape in the human aging brains with Alzheimer's diseaseAmit Kumar Gupta, William Martin, Andrew A Pieper, et al.
Brain Research|June 3, 1999
Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemiaK Takahashi, A A Pieper, S E Croul, et al.
Eneuro|February 13, 2024
Mice Expressing A53T/A30P Mutant Alpha-Synuclein in Dopamine Neurons Do Not Display Behavioral DeficitsCameron Keomanivong, Josephine Schamp, Ervina Tabakovic, et al.
Pageof 28

Showing results (121-130 of 278) with videos related to

Sort By:
Pageof 28
Journal of the American Association for Laboratory Animal Science : JAALAS|July 11, 2012
Normal hematologic and serum biochemical values of cotton-top tamarins (Saguinus oedipus)Evan T Shukan, Carla Y Boe, Aimee V Hasenfus, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Propranolol pharmacokinetics and pharmacodynamics after single doses and at steady-stateR L Lalonde, J A Pieper, R J Straka, et al.
Clinical Pharmacology and Therapeutics|July 1, 1988
Effect of calcium channel blockers on theophylline dispositionS M Sirmans, J A Pieper, R L Lalonde, et al.
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1987
Propranolol pharmacodynamic modeling using unbound and total concentrations in healthy volunteersR L Lalonde, R J Straka, J A Pieper, et al.
The Journal of Prevention of Alzheimer'S Disease|October 27, 2025
The role for artificial intelligence in identifying combination therapies for Alzheimer's diseaseFeixiong Cheng, Zhendong Sha, Yadi Zhou, et al.
Journal of Pharmaceutical Sciences|July 1, 1987
Nonlinear pharmacokinetics of unbound propranolol after oral administrationR J Straka, R L Lalonde, J A Pieper, et al.
Journal of Clinical Pharmacology|April 10, 1999
The effects of fluvastatin, a CYP2C9 inhibitor, on losartan pharmacokinetics in healthy volunteersA M Meadowcroft, K M Williamson, J H Patterson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 9, 2025
Comprehensive characterization of the RNA editing landscape in the human aging brains with Alzheimer's diseaseAmit Kumar Gupta, William Martin, Andrew A Pieper, et al.
Brain Research|June 3, 1999
Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemiaK Takahashi, A A Pieper, S E Croul, et al.
Eneuro|February 13, 2024
Mice Expressing A53T/A30P Mutant Alpha-Synuclein in Dopamine Neurons Do Not Display Behavioral DeficitsCameron Keomanivong, Josephine Schamp, Ervina Tabakovic, et al.
Pageof 28